UVRAG
Basic information
Region (hg38): 11:75815210-76144232
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UVRAG gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 51 | 52 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 0 | |||||
Total | 0 | 0 | 51 | 2 | 1 |
Variants in UVRAG
This is a list of pathogenic ClinVar variants found in the UVRAG region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-75815413-C-A | not specified | Uncertain significance (Apr 20, 2024) | ||
11-75815459-C-T | not specified | Uncertain significance (May 30, 2023) | ||
11-75815510-C-A | not specified | Uncertain significance (Apr 07, 2022) | ||
11-75851914-C-T | not specified | Uncertain significance (May 11, 2022) | ||
11-75851970-C-T | not specified | Uncertain significance (Dec 27, 2022) | ||
11-75851976-T-C | not specified | Uncertain significance (Nov 12, 2021) | ||
11-75851994-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
11-75879886-C-T | not specified | Uncertain significance (May 14, 2024) | ||
11-75879912-A-G | not specified | Uncertain significance (Feb 03, 2022) | ||
11-75879948-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
11-75879982-A-T | not specified | Uncertain significance (Dec 06, 2022) | ||
11-75879994-T-C | not specified | Uncertain significance (May 14, 2024) | ||
11-75888831-T-G | not specified | Uncertain significance (Aug 21, 2023) | ||
11-75888896-A-G | Malignant tumor of prostate | Uncertain significance (-) | ||
11-75888910-A-C | Likely benign (May 31, 2018) | |||
11-75911978-A-G | not specified | Uncertain significance (Mar 29, 2023) | ||
11-75912008-C-T | not specified | Uncertain significance (Jan 27, 2022) | ||
11-75912020-G-A | not specified | Uncertain significance (Mar 22, 2023) | ||
11-75912042-A-G | Benign (May 31, 2018) | |||
11-75961485-C-T | not specified | Uncertain significance (Feb 03, 2022) | ||
11-75961542-A-G | not specified | Uncertain significance (Jul 19, 2023) | ||
11-75983387-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
11-75983402-T-C | not specified | Uncertain significance (Feb 14, 2024) | ||
11-75983418-T-G | not specified | Uncertain significance (Dec 03, 2021) | ||
11-75983435-G-A | not specified | Uncertain significance (Nov 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UVRAG | protein_coding | protein_coding | ENST00000356136 | 15 | 328028 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.989 | 0.0106 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.49 | 289 | 369 | 0.782 | 0.0000205 | 4535 |
Missense in Polyphen | 80 | 120.51 | 0.66385 | 1395 | ||
Synonymous | 0.610 | 132 | 141 | 0.935 | 0.00000783 | 1376 |
Loss of Function | 4.76 | 5 | 35.7 | 0.140 | 0.00000189 | 442 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000177 | 0.000177 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000442 | 0.0000439 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Versatile protein that is involved in regulation of different cellular pathways implicated in membrane trafficking. Involved in regulation of the COPI-dependent retrograde transport from Golgi and the endoplasmic reticulum by associating with the NRZ complex; the function is dependent on its binding to phosphatidylinositol 3-phosphate (PtdIns(3)P) (PubMed:24056303). During autophagy acts as regulatory subunit of the alternative PI3K complex II (PI3KC3-C2) that mediates formation of phosphatidylinositol 3-phosphate and is believed to be involved in maturation of autophagosomes and endocytosis. Activates lipid kinase activity of PIK3C3. Involved in the regulation of degradative endocytic trafficking and cytokinesis, and in regulation of ATG9A transport from the Golgi to the autophagosome; the functions seems to implicate its association with PI3KC3-C2 (PubMed:16799551, PubMed:20643123, PubMed:24056303). Involved in maturation of autophagosomes and degradative endocytic trafficking independently of BECN1 but depending on its association with a class C Vps complex (possibly the HOPS complex); the association is also proposed to promote autophagosome recruitment and activation of Rab7 and endosome-endosome fusion events (PubMed:18552835). Enhances class C Vps complex (possibly HOPS complex) association with a SNARE complex and promotes fusogenic SNARE complex formation during late endocytic membrane fusion (PubMed:24550300). In case of negative-strand RNA virus infection is required for efficient virus entry, promotes endocytic transport of virions and is implicated in a VAMP8-specific fusogenic SNARE complex assembly (PubMed:24550300). {ECO:0000269|PubMed:18552835, ECO:0000269|PubMed:20643123, ECO:0000269|PubMed:24056303, ECO:0000305}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving UVRAG has been observed in a patient with heterotaxy (left-right axis malformation). Inversion Inv(11)(q13.5;q25). {ECO:0000269|PubMed:10798355}.;
- Pathway
- Autophagy - animal - Homo sapiens (human);Nanoparticle triggered autophagic cell death;Senescence and Autophagy in Cancer
(Consensus)
Recessive Scores
- pRec
- 0.0998
Intolerance Scores
- loftool
- 0.482
- rvis_EVS
- -0.37
- rvis_percentile_EVS
- 28.16
Haploinsufficiency Scores
- pHI
- 0.198
- hipred
- Y
- hipred_score
- 0.735
- ghis
- 0.539
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.999
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Uvrag
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); immune system phenotype;
Zebrafish Information Network
- Gene name
- uvrag
- Affected structure
- melanocyte
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- DNA repair;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;autophagy;spindle organization;chromosome segregation;centrosome cycle;regulation of cytokinesis;receptor catabolic process;SNARE complex assembly;viral entry into host cell;maintenance of Golgi location;regulation of protein serine/threonine kinase activity;multivesicular body sorting pathway;double-strand break repair via classical nonhomologous end joining;positive regulation of autophagosome maturation
- Cellular component
- chromosome, centromeric region;cytoplasm;lysosome;early endosome;late endosome;endoplasmic reticulum;centrosome;midbody;HOPS complex;phagocytic vesicle;DNA-dependent protein kinase complex
- Molecular function
- SNARE binding;protein binding;SH3 domain binding